SFBS:NYSEServisFirst Bancshares, Inc. Analysis
Data as of 2026-05-30 - not real-time
$77.99
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
ServisFirst Bancshares is trading well below its discounted cash flow estimate, offering a sizable upside potential. The stock sits near its 20‑day simple moving average, with the 50‑day SMA slightly higher, indicating a neutral technical stance. Momentum indicators show a bullish MACD histogram despite a modestly negative MACD line, suggesting emerging strength. Volume has been on a decreasing trend, which tempers short‑term enthusiasm but also reduces downside pressure. The company posted strong revenue growth and high operating margins, outpacing many regional peers. Profitability metrics such as ROE are solid, and the forward earnings multiple is comfortably below the industry average. A dividend yield approaching 2% coupled with a low payout ratio underscores sustainable dividend potential. Balance‑sheet analysis reveals ample cash reserves relative to debt, mitigating solvency concerns. Market sentiment is in an “Extreme Greed” phase, which could inflate short‑term price action. Recent earnings missed analyst estimates, introducing a modest near‑term uncertainty. However, management reaffirmed confidence in the business model and dividend policy. Overall, the combination of undervaluation, resilient fundamentals, and a supportive dividend profile makes the stock attractive for investors with a medium‑to‑long horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Neutral technical positioning near moving averages
- Decreasing volume indicating limited short‑term momentum
- Sustainable dividend providing income cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap to DCF fair value
- Strong revenue and operating margin growth
- Low payout ratio supporting dividend continuity
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust ROE and cash generation capacity
- Regional banking recovery potential with favorable interest‑rate outlook
- Consistent dividend policy enhancing total return
Key Metrics & Analysis
Financial Health
Revenue Growth18.50%
Profit Margin53.99%
P/E Ratio13.9
ROE16.55%
ROA1.61%
P/B Ratio2.2
Op. Cash Flow$377.4M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI52.4
Support$74.47
Resistance$81.21
MA 20$77.62
MA 50$76.80
MA 200$77.95
MACDBullish
VolumeDecreasing
Fear & Greed Index94.07
Valuation
Fair Value$119.00
Target Price$94.33
Upside/Downside20.96%
GradeUndervalued
TypeBlend
Dividend Yield1.96%
Risk Assessment
Beta1.16
Volatility21.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.